The Generic Drug Battle By: Benzinga via Benzinga February 10, 2016 at 09:13 AM EST On Tuesday, a U.S. regulatory panel voted in favor of the Food and Drug Administration approving a knockoff arthritis drug that would ... Read More >> Related Stocks: AbbVie Amgen Johnson & Johnson Pfizer